A systems model of altered consciousness: integrating natural and drug-induced psychoses

@article{Vollenweider2001ASM,
  title={A systems model of altered consciousness: integrating natural and drug-induced psychoses},
  author={Franz X. Vollenweider and Mark A Geyer},
  journal={Brain Research Bulletin},
  year={2001},
  volume={56},
  pages={495-507}
}

Figures and Tables from this paper

Brain mechanisms of hallucinogens and entactogens
TLDR
Recent brain imaging and behavioral studies of sensory gating functions suggest that disruption of cortico-subcortical processing leading to sensory overload of the cortex is a communality of these psychoses.
Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency
TLDR
Ketamine administration elicited effects on psychopathology, including difficulties in abstract thinking, lack of spontaneity and flow of conversation as well as formal thought disorder, and NMDAR blocking evoked psychopathological symptoms and cortical activations in regions previously reported in schizophrenia patients.
Classic Psychedelic Drugs: Update on Biological Mechanisms
Renewed interest in the effects of psychedelics in the treatment of psychiatric disorders warrants a better understanding of the neurobiological mechanisms underlying the effects of these substances.
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
TLDR
It is considered the possibility that agents that attenuate these two components of NMDA receptor antagonist response may play complementary roles in the treatment of schizophrenia.
A Kappa Opioid Model of Atypical Altered Consciousness and Psychosis: U50488, DOI, AC90179 Effects on Prepulse Inhibition and Locomotion in Mice.
TLDR
Investigation of the anomalous opioid sub-type, the kappa opioid (KA) system, within the two ASC models suggests that KA could function as an atypical antipsychotic medications and/or as a screening tool for new antipsychotics.
The psychotomimetic effects of PCP , LSD and MDMA : Pharmacological models of schizophrenia ?
TLDR
The primary question addressed herein, whether PCP-induced psychosis is a valid model of schizophrenia, gives rise to additional questions about the validity of ketamine challenge at subanaesthetic doses in humans as a model of PCP psychosis, and in turn, questions aboutThe validity of drug-induced changes in non-human animals (rodents, monkeys) treated with PCP and its analogues (ketamine or dizocilpine [MK-801]) as models of PCPs psychosis.
Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States
TLDR
Recent findings of thalamocortical dysconnectivity, its putative extension to CSPTC circuitry, along with its clinical implications and future directions are discussed.
Serotonin research: contributions to understanding psychoses.
Impact of Ketamine on Neuronal Network Dynamics: Translational Modeling of Schizophrenia‐Relevant Deficits
TLDR
Recent studies that determine the effect of ketamine on simple neurophysiological measures and to what extent they recapitulate findings in patients with schizophrenia are reviewed.
Identification of a Novel Serotonin / Glutamate Receptor Complex Implicated in Psychosis
TLDR
It is shown that the mGluR2 interacts via specific transmembrane helix domains with the 2AR, a member of an unrelated G protein-coupled receptor (GPCR) family, to form functional complexes in brain cortex, and represents a promising new target for the treatment of psychosis.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 189 REFERENCES
Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.
TLDR
The data demonstrate that the neuronal substrate of normal and abnormal thought and behavior is associated with a distributed neuronal network and with multiple interactive neurotransmitter systems, and support the view that the hallucinogen challenge paradigm constitutes a powerful tool for elucidating the pathophysiology of neuropsychiatric disorders.
Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research.
  • M. Geyer
  • Psychology, Biology
    Pharmacopsychiatry
  • 1998
TLDR
The cross-species study of homologous gating functions, such as habituation and PPI, in animal models and psychiatric patients provides novel opportunities for the exploration of neurobiological substrates relevant to the group of schizophrenias.
Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia.
TLDR
Several different ways the loss of PPI in rats can be used as a model for studying the pathophysiology and neurobiology of impaired sensorimotor gating in schizophrenia patients and for predicting antipsychotic activity in novel compounds are described.
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers.
TLDR
Data suggest that the prefrontal cortex may be involved in mediating NMDA receptor-induced psychosis, and a change in one psychotic symptom, conceptual disorganization, was significantly related to prefrontal activation.
Dopamine, schizophrenia, mania, and depression: Toward a unified hypothesis of cortico-striatopallido-thalamic function
TLDR
A neural model is described that parallels existing explanations for the etiology of several movement disorders, and may lead to testable inferences regarding the neural substrates of specific psychopathologies.
Ketamine activates psychosis and alters limbic blood flow in schizophrenia
The non-competitive NMDA antagonist ketamine, given to schizophrenic individuals in subanesthetic doses, produced a short-lived, discrete activation of their psychotic symptoms, which had striking
...
1
2
3
4
5
...